Patent · US Active

Methods to produce bunyavirus replicon particles

US9109199B2 · kind B2 · utility

4Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2011
Grant dateAug 18, 2015
Priority date
Expiry dateSep 20, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to methods of producing infectious bunyavirus replicon particles. These bunyavirus replicon particles are safe and can be used outside a biosafety containment. The invention further relates to recombinant bunyavirus replicon particles and uses of these recombinant bunyavirus replicon particles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.